BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21315120)

  • 1. Selective gene transfection of individual cells in vitro with plasmonic nanobubbles.
    Lukianova-Hleb EY; Samaniego AP; Wen J; Metelitsa LS; Chang CC; Lapotko DO
    J Control Release; 2011 Jun; 152(2):286-93. PubMed ID: 21315120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tunable plasmonic nanobubbles for cell theranostics.
    Lukianova-Hleb EY; Hanna EY; Hafner JH; Lapotko DO
    Nanotechnology; 2010 Feb; 21(8):85102. PubMed ID: 20097970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmonic nanobubbles as transient vapor nanobubbles generated around plasmonic nanoparticles.
    Lukianova-Hleb E; Hu Y; Latterini L; Tarpani L; Lee S; Drezek RA; Hafner JH; Lapotko DO
    ACS Nano; 2010 Apr; 4(4):2109-23. PubMed ID: 20307085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient photothermal spectra of plasmonic nanobubbles.
    Lukianova-Hleb EY; Sassaroli E; Jones A; Lapotko DO
    Langmuir; 2012 Mar; 28(10):4858-66. PubMed ID: 22339620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser pulse duration is critical for the generation of plasmonic nanobubbles.
    Lukianova-Hleb EY; Volkov AN; Lapotko DO
    Langmuir; 2014 Jul; 30(25):7425-34. PubMed ID: 24916057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective and self-guided micro-ablation of tissue with plasmonic nanobubbles.
    Lukianova-Hleb EY; Koneva II; Oginsky AO; La Francesca S; Lapotko DO
    J Surg Res; 2011 Mar; 166(1):e3-13. PubMed ID: 21176913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optically guided controlled release from liposomes with tunable plasmonic nanobubbles.
    Anderson LJ; Hansen E; Lukianova-Hleb EY; Hafner JH; Lapotko DO
    J Control Release; 2010 Jun; 144(2):151-8. PubMed ID: 20156498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmonic nanobubbles as tunable cellular probes for cancer theranostics.
    Lapotko D
    Cancers (Basel); 2011 Feb; 3(1):802-40. PubMed ID: 21442036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tunable plasmonic nanoprobes for theranostics of prostate cancer.
    Lukianova-Hleb EY; Oginsky AO; Samaniego AP; Shenefelt DL; Wagner DS; Hafner JH; Farach-Carson MC; Lapotko DO
    Theranostics; 2011 Jan; 1():3-17. PubMed ID: 21547151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and detection of plasmonic nanobubbles in zebrafish.
    Lukianova-Hleb EY; Santiago C; Wagner DS; Hafner JH; Lapotko DO
    Nanotechnology; 2010 Jun; 21(22):225102. PubMed ID: 20453288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmonic nanobubbles rapidly detect and destroy drug-resistant tumors.
    Lukianova-Hleb EY; Ren X; Townley D; Wu X; Kupferman ME; Lapotko DO
    Theranostics; 2012; 2(10):976-87. PubMed ID: 23139725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-specific transmembrane injection of molecular cargo with gold nanoparticle-generated transient plasmonic nanobubbles.
    Lukianova-Hleb EY; Wagner DS; Brenner MK; Lapotko DO
    Biomaterials; 2012 Jul; 33(21):5441-50. PubMed ID: 22521612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts.
    Wagner DS; Delk NA; Lukianova-Hleb EY; Hafner JH; Farach-Carson MC; Lapotko DO
    Biomaterials; 2010 Oct; 31(29):7567-74. PubMed ID: 20630586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for Generation and Detection of Nonstationary Vapor Nanobubbles Around Plasmonic Nanoparticles.
    Lukianova-Hleb EY; Lapotko DO
    Methods Mol Biol; 2017; 1530():165-192. PubMed ID: 28150203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain.
    Harmon BT; Aly AE; Padegimas L; Sesenoglu-Laird O; Cooper MJ; Waszczak BL
    Gene Ther; 2014 May; 21(5):514-21. PubMed ID: 24670994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent zinc(ii) complexes for gene delivery and simultaneous monitoring of protein expression.
    Rane LB; Kate AN; Ramteke SN; Shravage BV; Kulkarni PP; Kumbhar AA
    Dalton Trans; 2016 Nov; 45(42):16984-16996. PubMed ID: 27711702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser-assisted microinjection into targeted animal cells.
    Mohanty SK; Sharma M; Gupta PK
    Biotechnol Lett; 2003 Jun; 25(11):895-9. PubMed ID: 12889802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems.
    Lukianova-Hleb EY; Ren X; Constantinou PE; Danysh BP; Shenefelt DL; Carson DD; Farach-Carson MC; Kulchitsky VA; Wu X; Wagner DS; Lapotko DO
    PLoS One; 2012; 7(4):e34537. PubMed ID: 22509318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimisation of transfection conditions of CD34+ hematopoietic cells derived from human umbilical cord blood.
    Ołdak T; Kruszewski M; Machaj EK; Gajkowska A; Pojda Z
    Acta Biochim Pol; 2002; 49(3):625-32. PubMed ID: 12422232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of integrin-mediated transfection of haematopoietic cells with a synthetic vector system.
    Uduehi A; Mailhos C; Truman H; Thrasher AJ; Kinnon C; Hart SL
    Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):201-9. PubMed ID: 12812522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.